{"product_id":"bpc-157-tb500-bacteriostatic-water-research-kit","title":"BPC-157 + TB500 + Bacteriostatic Water Research Kit","description":"\u003cp\u003e\u003cstrong\u003eCertificate of Analysis (COA): See Images \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe Complete Research Protocol: BPC-157, TB-500 \u0026amp; Solvent.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis research bundle provides the three essential components required for high-level regenerative study: 5mg of BPC-157, 5mg of TB-500, and 10ml of Bacteriostatic Water. By supplying these compounds in their pure, lyophilized states alongside the necessary solvent, researchers can ensure maximum stability and precise concentration control at the time of reconstitution.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIMPORTANT: Why We Do Not Sell \"Pre-Blended\" Vials\u003c\/strong\u003e\u003cbr\u003eAt Tide Labs, we prioritize chemical integrity over convenience. While other vendors may sell single vials containing both peptides mixed together, we refuse to do so. BPC-157 and TB-500 have different molecular weights, pH stability requirements, and degradation rates. Mixing them in a solution for long-term storage or during the lyophilization process often leads to the degradation of one or both peptides before they even reach the lab bench.\u003cbr\u003eTo understand the science behind why separate vials are the only professional choice, read our full analysis: \u003ca href=\"https:\/\/tidelabs.co.uk\/blogs\/articles\/why-tide-labs-doesn-t-mix-bpc-157-tb-500-and-why-blended-vials-don-t-add-up\" title=\"Why Tide Labs Doesn't Mix BPC-157 \u0026amp; TB-500\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eWhy Tide Labs Doesn't Mix BPC-157 \u0026amp; TB-500\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch3\u003eArea of Interest\u003c\/h3\u003e\n\u003cp\u003eResearchers have investigated the BPC-157 + TB-500 combination across several areas of preclinical and laboratory study. The inclusion of bacteriostatic water allows for immediate and sterile reconstitution for experimental application:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Healing:\u003c\/strong\u003e Both peptides are explored for their roles in supporting tendon, ligament, and muscle recovery in injury models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAngiogenesis \u0026amp; Blood Flow:\u003c\/strong\u003e TB-500 has been studied for promoting new blood vessel growth, while BPC-157 has been linked with protective effects on vascular tissue.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnti-Inflammatory Potential:\u003c\/strong\u003e Evidence suggests both peptides may influence inflammatory pathways, making the concurrent study of these separate compounds highly relevant in chronic injury research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynergistic Effects:\u003c\/strong\u003e By combining BPC-157’s focus on gut and connective tissue repair with TB-500’s angiogenic and cellular migration properties, researchers are exploring whether the protocol offers a broader range of regenerative potential.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis combination is regarded in research settings as a versatile and promising area of study within peptide science.\u003c\/p\u003e\n\u003ch3\u003eTechnical Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemical Names:\u003c\/strong\u003e Pentadecapeptide BPC-157 \u0026amp; Thymosin Beta-4 Fragment (TB-500)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKit Contents:\u003c\/strong\u003e 1x BPC-157 (5mg), 1x TB-500 (5mg), 1x Bacteriostatic Water (10ml)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSolvent Composition:\u003c\/strong\u003e Sterile Water with 0.9% Benzyl Alcohol (Bacteriostatic agent)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula (BPC-157):\u003c\/strong\u003e C₆₂H₉₈N₁₆O₂₂\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight (BPC-157):\u003c\/strong\u003e 1419.53 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula (TB-500):\u003c\/strong\u003e C₂₁₂H₃₅₀N₅₆O₇₈S\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight (TB-500):\u003c\/strong\u003e ~4963 g\/mol (full Thymosin Beta-4 fragment equivalent)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeptide Classification:\u003c\/strong\u003e Synthetic peptides – BPC-157 derived from gastric protein, TB-500 derived from Thymosin Beta-4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eStorage Guidelines\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eLyophilized peptides (powder) are stable at room temperature for short periods.\u003c\/li\u003e\n\u003cli\u003eFor long-term storage of the powder vials, keep at −20°C or below.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBacteriostatic Water:\u003c\/strong\u003e Store at room temperature (15–25°C). Do not freeze.\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eOnce reconstituted (mixed), store peptide solutions at 2–8 °C. The Benzyl Alcohol in the solvent preserves sterility for up to 28 days after opening.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSolubility\u003c\/h3\u003e\n\u003cp\u003eBoth peptides are fully soluble in the included Bacteriostatic Water. The 10ml volume allows for flexible concentration ratios depending on the specific requirements of the research protocol.\u003c\/p\u003e\n\u003ch3\u003eReferences\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSikiric, P., Seiwerth, S., Grabarevic, Z., et al. (2001). “A new gastric juice peptide, BPC, heals both acute and chronic gastrointestinal lesions.” \u003cem\u003eJournal of Physiology (Paris)\u003c\/em\u003e, 95(1-6), 79–92. \u003ca rel=\"noopener noreferrer\" href=\"https:\/\/doi.org\/10.1016\/S0928-4257(01)00011-5\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1016\/S0928-4257(01)00011-5\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003ePhilp, D., Badamchian, M., Scheremeta, B., et al. (2003). “Thymosin beta4 and angiogenesis: initiation of new blood vessel growth.” \u003cem\u003eAnnals of the New York Academy of Sciences\u003c\/em\u003e, 1002, 168–177. \u003ca rel=\"noopener noreferrer\" href=\"https:\/\/doi.org\/10.1196\/annals.1283.018\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1196\/annals.1283.018\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eMalinda, K. M., Sidhu, G. S., Mani, H., et al. (1999). “Thymosin beta4 accelerates wound healing.” \u003cem\u003eJournal of Investigative Dermatology\u003c\/em\u003e, 113(3), 364–368. \u003ca rel=\"noopener noreferrer\" href=\"https:\/\/doi.org\/10.1046\/j.1523-1747.1999.00705.x\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.1046\/j.1523-1747.1999.00705.x\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eSeiwerth, S., Rucman, R., Turkovic, B., et al. (2014). “Stable gastric pentadecapeptide BPC 157: novel mediator of Robert’s cytoprotection and adaptive cytoprotection.” \u003cem\u003eCurrent Pharmaceutical Design\u003c\/em\u003e, 20(7), 1126–1135. \u003ca rel=\"noopener noreferrer\" href=\"https:\/\/doi.org\/10.2174\/13816128113199990435\" target=\"_blank\"\u003ehttps:\/\/doi.org\/10.2174\/13816128113199990435\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCertificate of Analysis (COA):\u003c\/strong\u003e See Images \u003c\/p\u003e","brand":"Tide Labs","offers":[{"title":"Default Title","offer_id":52357567840599,"sku":null,"price":42.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0941\/3142\/1527\/files\/BPTBBAC.webp?v=1779829651","url":"https:\/\/tidelabs.co.uk\/products\/bpc-157-tb500-bacteriostatic-water-research-kit","provider":"Tide Labs ","version":"1.0","type":"link"}